insights_auto
Why is YATHARTH up 4.80%?
Dive Deeperchevron_right
YATHARTH:NSE
Yatharth Hospital & Trauma Cre Srvcs Ltd
â‚ą1,029.00
arrow_upward
+4.80%(+47.15) 1D
Nov 4, 3:30:02 PM GMT+5:30 · INR
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for YATHARTH...
Open
â‚ą1,000.00
High
â‚ą1,036.00
Low
â‚ą988.85
Mkt. cap
99.15B
Avg. vol.
405.86K
Volume
705.93K
Dividend
0.05%
Quarterly dividend
â‚ą0.13
Ex-dividend date
Aug 14, 2026
P/E ratio
54.96
52-wk high
â‚ą1,184.00
52-wk low
â‚ą538.25
EPS
â‚ą18.72
No. of employees
7K
Open
â‚ą1,000.00
High
â‚ą1,036.00
Low
â‚ą988.85
Mkt. cap
99.15B
Avg. vol.
405.86K
Volume
705.93K
Dividend
0.05%
Quarterly dividend
â‚ą0.13
Ex-dividend date
Aug 14, 2026
P/E ratio
54.96
52-wk high
â‚ą1,184.00
52-wk low
â‚ą538.25
EPS
â‚ą18.72
No. of employees
7K
News stories
From web sources and news partners
Investing.com
·
15 hours ago
Earnings call transcript: Yatharth Hospital Q2 2026 revenue beats forecast
Profile
Yatharth Hospital & Trauma Care Services Ltd is an Indian for-profit private hospital chain of North India. As of October 2026, Yatharth group operates 8 hospitals in North India, and has acquired its ninth hospital in Gurugram, taking the group’s total capacity to over 2,800 beds. It was founded by Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar in 2008. Its facility in Greater Noida West is the first and only hospital in Uttar Pradesh to be accredited by Joint Commission International. Wikipedia
About Yatharth Hospital & Trauma Cre Srvcs Ltd
CEO-
Employees7.44K
Founded2008
Headquarters-
SectorHealth care provider
Industry-
Websiteyatharthhospitals.com
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in INR | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 2.79B | 3.20B | 3.50B | 3.93B |
Cost of goods sold | 1.10B | 1.26B | 1.31B | 1.47B |
Cost of revenue | 1.10B | 1.26B | 1.31B | 1.47B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | - | - | 309.43M | - |
Operating expense | 1.24B | 1.44B | 1.58B | 1.82B |
Total operating expenses | 2.34B | 2.70B | 2.90B | 3.29B |
Operating income | 455.91M | 502.89M | 598.44M | 634.44M |
Other non operating income | 94.89M | 78.25M | -231.48M | 43.53M |
EBT including unusual items | 548.23M | 570.97M | 529.52M | 612.05M |
EBT excluding unusual items | 548.23M | 570.97M | 506.66M | 612.05M |
Income tax expense | 135.70M | 140.14M | 90.22M | 157.82M |
Effective tax rate | 24.75% | 24.54% | 17.04% | 25.79% |
Other operating expenses | 1.05B | 1.20B | 974.49M | 1.54B |
Net income | 412.42M | 453.51M | 467.52M | 470.61M |
Net profit margin | 14.76% | 14.15% | 13.38% | 11.99% |
Earnings per share | - | - | - | - |
Interest and investment income | - | - | 195.32M | - |
Interest expense | -2.57M | -10.17M | -50.71M | -65.92M |
Net interest expenses | -2.57M | -10.17M | 144.61M | -65.92M |
Depreciation and amortization charges | 189.31M | 239.60M | 299.96M | 282.38M |
EBITDA | 625.16M | 639.36M | 807.46M | 853.96M |
Gain or loss from assets sale | - | - | - | - |
Upcoming events